TRUBAR Inc. Stocks

CA$ 0.77Last Updated 17.06.2025

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

CA$ 71.85M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CA$ 0.77
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Simply Better Brands Corp. manufactures and sells hemp-based cannabidiol related products in the United States. The company offers tinctures, topicals, capsules, gummies, pet tinctures and treats, bath bombs, pet wellness products, and skincare products comprising caffeine eye cream, retinol night cream, charcoal peel-off masks, moisturizers, serums, toner, cleanser, and acne patches. It also provides nutritious bars. The company offers its products under the PureKana, Tru Brand, BudaPets, and No BS brands. Simply Better Brands Corp. sells its products through its own e-commerce platforms, and brick and mortar retailers. The company was formerly known as PureK Holdings Corp. and changed its name to Simply Better Brands Corp. in May 2021. The company was founded in 2017 and is headquartered in Vancouver, Canada. Simply Better Brands Corp. is a subsidiary of Heavenly Rx Ltd.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is overvalued on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7

The average target price of SBBC.V is 1.7 and suggests 88% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks